Use of glycohemoglobin and microalbuminuria in diagnosis and monitoring of diabetes mellitus
Completed: 2002 Investigators Sherita Hill Golden, MD, MHS
Frederick L. Brancati, MD, MHS
Ebony Boulware, MD, MPH
Eliseo Guallar, MD, DrPH
Tejal Rami, MPH
Spyridon S. Marinopoulos, MD, MBA
Neil Powe, MD, MPH, MBA
Questions
The following research questions are being addressed: What is the relationship between HbA1c and microvascular diabetic complications (retinopathy, nephropathy, and neuropathy [peripheral and autonomic])? What is the relationship between HbA1c and macrovascular diabetic complications (coronary heart disease, cerebrovascular disease, peripheral vascular disease)? What is the risk relationship between microalbuminuria and change in glomerular filtration rate, cardiovascular disease morbidity and mortality, and all-cause mortality?
link to summary of report on AHRQ site link to evidence report on AHRQ site
|
